Skin cancer — all decisions

The Board granted the restoration of a 100 percent evaluation for malignant melanoma of the skin, effective from May 15, 2025.

The Board granted service connection for basal cell carcinoma, melanoma, and obstructive sleep apnea based on toxic exposure risk activity (TERA) during the Veteran's service.

The Board remands the claim for service connection for skin cancer to obtain an addendum medical opinion addressing the Veteran's exposure to jet fuel and firefighting foam.

The Board granted the restoration of a 100 percent disability rating for malignant melanoma, top of scalp effective March 1, 2022.

The Board granted service connection for the cause of death due to metastatic malignant melanoma, which was determined to be caused by toxic exposure during active duty. Accrued benefits were denied as no application was received within one year of the Veteran's death.

The Board granted service connection for an acquired psychiatric disability and skin cancer, but denied service connection for hemochromatosis.

The Board remands the claim for service connection of skin cancer to schedule a VA examination and obtain an opinion on the etiology of the Veteran's condition, including whether it is related to exposure to toxins during his service in Vietnam.

The Board remands the claims for a compensable rating for pre-cancerous melanoma, right eye and service connection for bilateral hearing loss, left ankle pain and instability, an acquired psychiatric disorder, bruxism, and sleep apnea to obtain additional evidence.

The Board granted service connection for melanoma under the PACT Act, presumptively linking it to the Veteran's exposure to burn pits during his deployment in Saudi Arabia.

The Board remands the claim for service connection for skin cancer, to include squamous cell and basal cell carcinoma, as further evidentiary development is required.

The Board remands the claim for a new medical opinion from a dermatologist to determine the nature and etiology of the Veteran's skin condition, as there was not substantial compliance with previous remand directives.

The Board remands the Veteran's claim for service connection for skin cancer due to a pre-decisional duty to assist error, as the July 2025 VA examination did not adequately address the Veteran's risk factors and UV exposure during service.

The Board granted service connection for bilateral tinnitus and an initial 70 percent rating, but not higher, for persistent depressive disorder with anxious distress. Other claims were denied or remanded.

The Board denied the veteran's claims for increased ratings and service connection, except for granting service connection for a left knee scar as secondary to his total knee replacement.

The Board remands the issue of entitlement to service connection for skin cancer and residuals therefrom due to a need for a VA examination and opinion in compliance with the PACT Act.

The Board denied earlier effective dates for the award of service connection for hypertension and CAD, granted a 10 percent evaluation for hypertension, and remanded several other claims.

The Board granted service connection for residuals of a skin condition, including basal cell carcinoma, squamous cell carcinoma, and melanoma.

The Board granted service connection for left, right upper and lower extremity peripheral neuropathy, chemotherapy induced, but remanded claims for skin cancer, colon cancer, and entitlement to a higher level of special monthly compensation.

The Board granted service connection for ischemic heart disease and diabetes mellitus type II, both presumed to be related to exposure to herbicides during ACDUTRA at Fort McClellan. The claims for benign prostatic hyperplasia, headaches, and skin cancer were remanded.

The Board denied service connection for skin cancer, finding that the Veteran's skin cancer is not etiologically related to his service.